Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
36.34
+0.01 (0.03%)
Oct 22, 2026, 4:00 PM EDT - Market closed
Pacira BioSciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,449 | 1,113 | 870 | 1,567 | 1,772 | 2,680 | |
Market Cap Growth | 40.04% | 27.99% | -44.48% | -11.55% | -33.91% | 3.10% |
Enterprise Value | 1,610 | 1,292 | 1,061 | 1,922 | 2,264 | 2,541 |
Last Close Price | 36.34 | 25.88 | 18.84 | 33.74 | 38.61 | 60.17 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 103.31 | 158.29 | - | 37.35 | 111.35 | 63.85 |
Forward PE | 11.76 | 7.53 | 7.10 | 10.23 | 11.64 | 15.43 |
PS Ratio | 1.94 | 1.53 | 1.24 | 2.32 | 2.66 | 4.95 |
PB Ratio | 2.15 | 1.61 | 1.12 | 1.80 | 2.29 | 3.67 |
P/TBV Ratio | 3.95 | 3.65 | 2.47 | 7.01 | 24.87 | - |
P/FCF Ratio | 8.07 | 8.15 | 4.87 | 11.23 | 15.38 | 33.57 |
P/OCF Ratio | 7.72 | 7.33 | 4.59 | 10.13 | 12.19 | 21.32 |
PEG Ratio | 1.18 | 0.54 | 0.54 | 0.54 | 0.53 | 0.66 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.16 | 1.78 | 1.51 | 2.85 | 3.40 | 4.69 |
EV/EBITDA Ratio | 12.98 | 10.40 | 6.01 | 11.80 | 14.91 | 21.45 |
EV/EBIT Ratio | 49.03 | 38.81 | 10.87 | 22.01 | 31.93 | 28.26 |
EV/FCF Ratio | 8.97 | 9.46 | 5.93 | 13.78 | 19.66 | 31.82 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.61 | 0.60 | 0.82 | 0.67 | 0.99 | 1.55 |
Debt / EBITDA Ratio | 2.97 | 3.00 | 3.33 | 3.28 | 4.55 | 8.54 |
Debt / FCF Ratio | 2.30 | 3.06 | 3.57 | 4.20 | 6.63 | 14.14 |
Net Debt / Equity Ratio | 0.24 | 0.26 | 0.20 | 0.35 | 0.61 | 0.65 |
Net Debt / EBITDA Ratio | 1.30 | 1.45 | 0.88 | 1.89 | 3.13 | 3.99 |
Net Debt / FCF Ratio | 0.90 | 1.32 | 0.86 | 2.20 | 4.12 | 5.92 |
Asset Turnover | 0.54 | 0.52 | 0.45 | 0.42 | 0.36 | 0.32 |
Inventory Turnover | 1.10 | 1.08 | 1.48 | 1.84 | 2.05 | 1.72 |
Quick Ratio | 3.21 | 3.01 | 1.93 | 3.95 | 2.63 | 1.45 |
Current Ratio | 5.04 | 4.54 | 2.40 | 5.24 | 3.37 | 1.66 |
Return on Equity (ROE) | 2.05% | 0.96% | -12.08% | 5.10% | 2.11% | 6.22% |
Return on Assets (ROA) | 1.48% | 1.48% | 3.90% | 3.35% | 2.36% | 3.36% |
Return on Invested Capital (ROIC) | 3.21% | 1.54% | 9.25% | 4.89% | 5.78% | 7.27% |
Return on Capital Employed (ROCE) | 2.90% | 2.90% | 7.80% | 5.90% | 4.60% | 5.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.97% | 0.63% | -11.45% | 2.68% | 0.90% | 1.57% |
FCF Yield | 12.39% | 12.27% | 20.55% | 8.90% | 6.50% | 2.98% |
Buyback Yield / Dilution | 7.82% | 2.60% | 11.03% | -11.69% | -1.99% | -4.46% |